ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Bioinformatics-based construction of prognosis-related methylation prediction model for pancreatic cancer patients and its application value

Cao, Tiansheng*; Wu, Hongsheng; Ji, Tengfei*南方医科大学
Frontiers in Pharmacology2023-3-9DOI: 10.3389/fphar.2023.1086309
17阅读
引用收藏
分享

摘要

Objective: Pancreatic adenocarcinoma (PAAD) is a highly malignant gastrointestinal tumor with almost similar morbidity and mortality. In this study, based on bioinformatics, we investigated the role of gene methylation in PAAD, evaluated relevant factors affecting patient prognosis, screened potential anti-cancer small molecule drugs, and constructed a prediction model to assess the prognosis of PAAD. @@@ Methods: Clinical and genomic data of PAAD were collected from the Tumor Genome Atlas Project (TCGA) database and gene expression profiles were obtained from the GTEX database. Analysis of differentially methylated genes (DMGs) and significantly differentially expressed genes (DEGs) was performed on tumorous samples with KRAS wild-type and normal samples using the "limma" package and combined analysis. We selected factors significantly associated with survival from the significantly differentially methylated and expressed genes (DMEGs), and their fitting into a relatively streamlined prognostic model was validated separately from the internal training and test sets and the external ICGC database to show the robustness of the model. @@@ Results: In the TCGA database, 2,630 DMGs were identified, with the largest gap between DMGs in the gene body and TSS200 region. 318 DEGs were screened, and the enrichment analysis of DMGs and DEGs was taken to intersect DMEGs, showing that the DMEGs were mainly related to Olfactory transduction, natural killer cell mediated cytotoxicity pathway, and Cytokine-cytokine receptor interaction. DMEGs were able to distinguish well between PAAD and paraneoplastic tissues. Through techniques such as drug database and molecular docking, we screened a total of 10 potential oncogenic small molecule compounds, among which felbamate was the most likely target drug for PAAD. We constructed a risk model through combining three DMEGs (S100P, LY6D, and WFDC13) with clinical factors significantly associated with prognosis, and confirmed the model robustness using external and internal validation. @@@ Conclusion: The classification model based on DMEGs was able to accurately separate normal samples from tumor samples and find potential anti-PAAD drugs by performing gene-drug interactions on DrugBank.

学科与关键词

关键词
pancreatic cancermethylationprognosisprediction modeldrugs
相关
加载中…
  • Classification and Prognosis Analysis of Pancreatic Cancer Based on DNA Methylation Profile and Clinical Information
    Li, Xin; Zhang, Xuan; Lin, Xiangyu; Cai, Liting; Wang, Yan*; Chang, Zhiqiang*Genes, 2022, 13(10): 1913.被引 5
  • A DNA-Methylation-Driven Genes Based Prognostic Signature Reveals Immune Microenvironment in Pancreatic Cancer
    Xiao, Mingjia; Liang, Xiangjing; Yan, Zhengming; Chen, Jingyang; Zhu, Yaru; Xie, Yuan; Li, Yang; Li, Xinming; Gao, Qingxiang; Feng, Feiling*; Fu, Gongbo*; Gao, Yi*Frontiers in Immunology, 2022, 13: 803962.被引 13
  • Development of a KRAS-Associated Metabolic Risk Model for Prognostic Prediction in Pancreatic Cancer
    Ma, Zuyi; Li, Zhenchong; Ma, Zuguang; Zhou, Zixuan; Zhuang, Hongkai; Liu, Chunsheng; Huang, Bowen; Zou, Yiping; Zheng, Zehao; Yang, LinLing; Gong, Yuanfeng; Huang, Shanzhou*; Zhou, Qi*; Zhang, Chuanzhao*; Hou, Baohua*Biomed Research International, 2021, 2021: 9949272.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Pharmacology
发表日期
2023-03-09
卷期
第 14 卷
页码
1086309
DOI
10.3389/fphar.2023.1086309
语言
ENGLISH
成果收录
SCIE
资助标注
Key Disciplines of Guangzhou Huadu District People's Hospital Project [2022-2025]

作者

  • C

    Cao, Tiansheng (通讯) (第一作者)

    southern med univ

  • W

    Wu, Hongsheng

    southern med univ

查看全部 3 位作者收起作者
  • J

    Ji, Tengfei (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417